These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26505327)

  • 1. Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events.
    Belcaro G; Dugall M; Ippolito E; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Cesarone MR; Pellegrini L; Luzzi R; Corsi M; Feragalli B
    Minerva Cardioangiol; 2017 Feb; 65(1):24-31. PubMed ID: 26505327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression.
    Belcaro G; Ippolito E; Dugall M; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Steigerwalt RD; Cesarone MR; Pellegrini L; Luzzi R; Corsi M
    Int Angiol; 2015 Apr; 34(2):150-7. PubMed ID: 25519846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques: 3-year prevention with the supplementation with Pycnogenol®+Centellicum®.
    Belcaro G; Cesarone MR; Scipione C; Scipione V; Dugall M; Shu H; Peterzan P; Corsi M; Luzzi R; Hosoi M; Feragalli B; Cotellese R
    Minerva Cardioangiol; 2020 Feb; 68(1):15-21. PubMed ID: 31625707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pycnogenol® and Centella Asiatica for asymptomatic atherosclerosis progression.
    Belcaro G; Dugall M; Hosoi M; Ippolito E; Cesarone M; Luzzi R; Cornelli U; Ledda A
    Int Angiol; 2014 Feb; 33(1):20-6. PubMed ID: 24452082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carotid plaque stabilization induced by the supplement association Pycnogenol® and centella asiatica (Centellicum®).
    Luzzi R; Belcaro G; Ippolito E
    Minerva Cardioangiol; 2016 Dec; 64(6):603-9. PubMed ID: 26496510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central cardiovascular calcifications: supplementation with Pycnogenol® and Centellicum®: variations over 12 months.
    Hu S; Belcaro G; Cesarone MR; Feragalli B; Cotellese R; Dugall M; Scipione C; Scipione V; Maione C
    Minerva Cardioangiol; 2020 Feb; 68(1):22-26. PubMed ID: 31633315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in Echogenicity in Carotid and Femoral Atherosclerotic Plaques with Pycnogenol + Centella Asiatica Supplementation.
    Belcaro G; Cornelli U
    Int J Angiol; 2017 Jun; 26(2):95-101. PubMed ID: 28566935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth.
    Belcaro G; Cesarone MR; Scipione C; Scipione V; Dugall M; Hu S; Feragalli B; Luzzi R; Hosoi M; Maione C; Cotellese R
    Minerva Cardioangiol; 2019 Dec; 67(6):450-455. PubMed ID: 31850725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keloidal penile fibrosis: improvements with Centellicum® (Centella asiatica) and Pycnogenol® supplementation: a pilot registry.
    Ledda A; Cornelli U; Belcaro G; Dugall M; Feragalli B; Cotellese R; Hu S; Corsi M
    Panminerva Med; 2020 Mar; 62(1):13-18. PubMed ID: 32199407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55.
    Belcaro G; Luzzi R; Dugall M; Ippolito E; Saggino A
    J Neurosurg Sci; 2014 Dec; 58(4):239-48. PubMed ID: 24675223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pycnogenol®-Centellicum® supplementation improves lung fibrosis and post-COVID-19 lung healing.
    Cesarone MR; Hu S; Belcaro G; Cornelli U; Feragalli B; Corsi M; Bombardelli E; Cotellese R; Hosoi M; Rosenkvist L
    Minerva Med; 2022 Feb; 113(1):135-140. PubMed ID: 34180638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress.
    Belcaro G; Dugall M; Ippolito E; Hu S; Saggino A; Feragalli B
    J Neurosurg Sci; 2015 Dec; 59(4):437-46. PubMed ID: 26635191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Episodic primary migraine headache: supplementary prophylaxis with Pycnogenol® prevents attacks and controls oxidative stress.
    Cesarone MR; Dugall M; Hu S; Belcaro G; Hosoi M; Scipione V; Scipione C; Cotellese R
    Panminerva Med; 2020 Jun; 62(2):102-108. PubMed ID: 31670494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study.
    Rodriguez P; Belcaro G; Dugall M; Hu S; Luzzi R; Ledda A; Ippolito E; Corsi M; Ricci A; Feragalli B; Cornelli U; Gizzi C; Hosoi M
    Panminerva Med; 2015 Sep; 57(3):121-5. PubMed ID: 25971329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Pycnogenol® on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study.
    Hu S; Belcaro G; Cornelli U; Luzzi R; Cesarone M; Dugall M; Feragalli B; Errichi B; Ippolito E; Grossi M; Hosoi M; Gizzi G; Trignani M
    Int Angiol; 2015 Feb; 34(1):43-52. PubMed ID: 25391252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the echogenicity of femoral plaques after treatment with total triterpenic fraction of Centella asiatica: a prospective, randomized, placebo-controlled trial.
    Incandela L; Belcaro G; Nicolaides AN; Cesarone MR; De Sanctis MT; Corsi M; Bavera P; Ippolito E; Griffin M; Geroulakos G; Sabetai M; Ramaswami G; Veller M
    Angiology; 2001 Oct; 52 Suppl 2():S69-73. PubMed ID: 11666127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in symptoms and cochlear flow with pycnogenol in patients with Meniere's disease and tinnitus.
    Luzzi R; Belcaro G; Hu S; Dugall M; Hosoi M; Cacchio M; Ippolito E; Corsi M
    Minerva Med; 2014 Jun; 105(3):245-54. PubMed ID: 24988090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-assessed plaque occurrence in the carotid and femoral arteries are independent predictors of cardiovascular events in middle-aged men during 10 years of follow-up.
    Davidsson L; Fagerberg B; Bergström G; Schmidt C
    Atherosclerosis; 2010 Apr; 209(2):469-73. PubMed ID: 19897198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Noninvasive Sonographic Study of Multisite Atherosclerosis in an Elderly Chinese Population.
    Huang M; Hippe DS; Huang L; Zhao X; Luo J; Zeng Q; Yuan C
    J Ultrasound Med; 2017 Mar; 36(3):639-647. PubMed ID: 28150376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study(1)).
    Belcaro G; Nicolaides AN; Ramaswami G; Cesarone MR; De Sanctis M; Incandela L; Ferrari P; Geroulakos G; Barsotti A; Griffin M; Dhanjil S; Sabetai M; Bucci M; Martines G
    Atherosclerosis; 2001 Jun; 156(2):379-87. PubMed ID: 11395035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.